Literature DB >> 31174818

Time to diagnosis of fibromyalgia and factors associated with delayed diagnosis in primary care.

Omer Gendelman1, Howard Amital2, Yael Bar-On3, Dana Ben-Ami Shor4, Daniela Amital5, Shmuel Tiosano6, Varda Shalev7, Gabriel Chodick7, Dahlia Weitzman7.   

Abstract

Fibromyalgia is a complex disorder, and its diagnosis often comprises a challenge for physicians. We aimed to assess the time from the appearance of early symptoms to the definite diagnosis of fibromyalgia and to delineate patient and physician factors associated with this delay. The database of a large healthcare services provider was searched for all fibromyalgia patients (age 21 years or more) diagnosed during 2008-2011. Patients with a diagnosis confirmed by a physician with a relevant specialization were compared with age- and sex-matched nonfibromyalgia controls to retrospectively identify an initial complaint pattern characteristic of fibromyalgia. The time from initial complaints to fibromyalgia diagnosis, as well as the fraction of time while the patient was treated continuously by the same primary physician as at time of diagnosis, was assessed among all eligible fibromyalgia patients. An initial complaint pattern was identified in 67.9% of 2,055 patients with confirmed fibromyalgia vs. 27.6% of 9,172 controls. Among 2,369 (69.0%) of all 3,434 eligible patients with fibromyalgia, mean (SD) total time to diagnosis was 6.42 (3.57) years and mean (SD) time while treated by the same primary physician as at diagnosis was 3.75 (3.26) years. Comorbidity, younger patient, and older physician age were associated with longer time to diagnosis. By analysis of "real-world" data, fibromyalgia remains a complex and elusive diagnosis, taking years to be properly diagnosed. There is a need to increase the awareness of this syndrome among physicians, especially of older age.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Anxiety; Diagnosis; Fibromyalgia; Rheumatic; Widespread pain

Mesh:

Year:  2019        PMID: 31174818     DOI: 10.1016/j.berh.2019.01.019

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  6 in total

1.  Diagnostic difficulty, delayed diagnosis, and increased tendencies of surgical treatment in fibromyalgia syndrome.

Authors:  Sevinç Külekçioğlu
Journal:  Clin Rheumatol       Date:  2021-10-21       Impact factor: 2.980

2.  ["But you've got to do something yourself as well" : Coping with fibromyalgia syndrome (FMS): perspectives of those affected and those treating them in Saarland].

Authors:  Marion Al-Qadi; Dagmar Renaud; Martha Meyer
Journal:  Schmerz       Date:  2020-09-22       Impact factor: 1.107

3.  Multivariate classification techniques and mass spectrometry as a tool in the screening of patients with fibromyalgia.

Authors:  Marcelo V S Alves; Lanaia I L Maciel; Ruver R F Ramalho; Leomir A S Lima; Boniek G Vaz; Camilo L M Morais; João O S Passos; Rodrigo Pegado; Kássio M G Lima
Journal:  Sci Rep       Date:  2021-11-19       Impact factor: 4.379

4.  Objective Diagnosis of Fibromyalgia Using Neuroretinal Evaluation and Artificial Intelligence.

Authors:  Luciano Boquete; Maria-José Vicente; Juan-Manuel Miguel-Jiménez; Eva-María Sánchez-Morla; Miguel Ortiz; Maria Satue; Elena Garcia-Martin
Journal:  Int J Clin Health Psychol       Date:  2022-02-23

5.  Effects of a mindfulness-based and acceptance-based group programme followed by physical activity for patients with fibromyalgia: a randomised controlled trial.

Authors:  Trond Haugmark; Kåre Birger Hagen; Sella Aarrestad Provan; Geir Smedslund; Heidi A Zangi
Journal:  BMJ Open       Date:  2021-06-29       Impact factor: 2.692

6.  Spectrochemical analysis in blood plasma combined with subsequent chemometrics for fibromyalgia detection.

Authors:  João Octávio Sales Passos; Marcelo Victor Dos Santos Alves; Camilo L M Morais; Francis L Martin; Antônio Felipe Cavalcante; Telma Maria Araújo Moura Lemos; Shayanne Moura; Daniel L D Freitas; João Vitor Medeiros Mariz; Jean Lucas Carvalho; Kássio M G Lima; Rodrigo Pegado
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.